Clinical Trial Update: Study to Determine Optimal Dose and Evaluate Safety, Tolerability, and Pharmacokinetics of Progerinin in Patients With Hutchinson-Gilford Progeria Syndrome (HGPS) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for Progerinin in Hutchinson-Gilford Progeria Syndrome to determine optimal dosing and assess safety, tolerability, and pharmaco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hutchinson-gilford Progeria Syndrome

Drugs mentioned

• Progerinin

Snippet

Sponsor: PRG Science & Technology Co., Ltd. | Conditions: Hutchinson-Gilford Progeria Syndrome | Phase 2 | Status: ACTIVE_NOT_RECRUITING